Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
6 Patents
#726 in Houston, TX
#2,905 in Texas
#44,981 in US
Tvardi Therapeutics, Inc.
Forward Citations = 15
8 inventors:
Houston, TX, United States of America
Tvardi Therapeutics, Inc.
EPO Patents = 3
Forward Citations = 15
Loading Chart...
Loading Chart...
8 inventors (with patents filed for the assignee):
Sofia De Achaval (6 out of 7 patents)
Imran Alibhai (4 out of 5 patents)
Beverly C Langevin (3 out of 4 patents)
4. Tian Zhou (3 out of 3 patents)
5. David John Tweardy (2 out of 6 patents)
6. Jeffrey Scott Larson (1 out of 21 patents)
7. Brad Henke (1 out of 2 patents)
8. William R Cantrell, Jr (11 patents)
9. William E Bauta (13 patents)
10. Sofia De Achaval Wied (0 patent)
11. Sofia De Achaval Wied (0 patent)
6 patents:
Company Overview
Tvardi Therapeutics, Inc. is a biotechnology company focused on developing targeted small molecule inhibitors for cancer treatment. Their innovative approach aims to deliver more effective and personalized therapies for cancer patients. With a strong team of scientists and researchers, Tvardi Therapeutics is dedicated to advancing the field of oncology and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tvardi Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tvardi-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]